AADELFA, La Plata, Argentina.
Servicio de Nefrología, Ipensa, La Plata, Argentina.
J Nephrol. 2022 Dec;35(9):2437-2440. doi: 10.1007/s40620-022-01405-x. Epub 2022 Aug 16.
We report three patients diagnosed with Fabry disease through a screening study which included individuals suffering from chronic kidney disease (CKD) at any stage. The study recruited 1740 male patients, and three Fabry patients were diagnosed, resulting in a frequency of 0.17%. The analysis by CKD stage group revealed frequencies of 3.03%, 0.77% and 0.17%, in CKD1, CKD3 and CKD5, respectively. Pedigree analysis was carried out for these families, with a high ratio index: pedigree (1:16). This study underlines the importance of considering Fabry disease in the differential diagnosis at every stage of CKD, including the early ones, and stresses the possibility of finding patients with late onset phenotypes.
我们通过一项包括各阶段慢性肾脏病(CKD)患者的筛查研究,诊断了三例法布瑞病患者。该研究共招募了 1740 名男性患者,诊断出了 3 例法布瑞病患者,发病率为 0.17%。按 CKD 阶段分组分析,在 CKD1、CKD3 和 CKD5 中,发病率分别为 3.03%、0.77%和 0.17%。对这些家系进行了系谱分析,高比值指数:家系(1:16)。本研究强调了在 CKD 的各个阶段(包括早期阶段)都要考虑法布瑞病的鉴别诊断,并且提示可能会发现迟发型表型的患者。